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Background: Current strategies in cancer treatment have markedly increased the rates of remission and survival for
cancer patients, but are often associated with subsequent sterility. While there are various options available to an
adult female depending on the patient’s particular situation, the only realistic option for preserving fertility in
prepubertal females is to cryopreserve ovarian tissue. This is the first report of a morphologically mature oocyte
collected from non-stimulated prepubertal ovarian tissue xenotransplants.
Methods: Ovarian tissue from a 6 year old patient suffering from nephroblastoma was removed and cryopreserved
for fertility preservation. The frozen-thawed ovarian tissue fragments were xenotransplanted to bilaterally
oophorectomized severe combined immunodeficiency (SCID) mice to assess follicle development.
Results: Antral follicle formation occurred post-xenotransplantation in a single ovarian fragment without exogenous
hormone stimulation. A morphologically maturing oocyte was harvested from these follicles.
Conclusions: Prepubertal human ovarian follicles and oocytes can be matured after xenotransplantation even without
exogenous hormone stimulation. These results indicate that tissue collected from prepubertal patients can support
fertility in cancer survivors.
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Metaphase II oocyteBackground
Advances in the treatment of oncological diseases have
led to greater survival rates for patients. However, treat-
ment often includes gonadotoxic therapies, which can
deplete germ cells and, in females, may result in prema-
ture ovarian failure in cancer survivors. While there are
various routes available to an adult female depending on
the patient’s particular situation, the only realistic option
for preserving fertility in prepubertal females is to cryo-
preserve ovarian tissue [1-4]. This technique is a promis-
ing tool because the ovarian cortex contains a large pool* Correspondence: ralf.dittrich@uk-erlangen.de
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unless otherwise stated.of follicles [5,6] and provides a high developmental
potential, especially in prepubertal patients [7,8].
The few transplantation studies of frozen-thawed pre-
pubertal ovarian tissue that have been reported indicate
that these grafts can support induction of puberty in
young cancer survivors [9,10] and may presumably sup-
port reproduction at the appropriate time. These results,
coupled with reports of more than 24 live births result-
ing from ovarian tissue cryopreservation and later trans-
plantation to women [11], demonstrate the potential of
the technique to move from the experimental realm to
routine clinical practice.
We report here the occurrence of spontaneous antral
follicle formation and oocyte maturation in an ovarian
tissue transplant from a prepubescent girl (6 years old at
the time of biopsy). To our knowledge, this is the first
report of a morphologically mature oocyte collected. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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transplants. These results further support the position
that tissue collected from these young patients can sup-
port fertility in cancer survivors.
Methods
Patient
In 2009 ovarian tissue from a 6 year old patient suffering
from nephroblastoma was removed and cryopreserved
following informed consent and approval of the local
university ethical committee (University Women’s Hos-
pital, Bonn, Germany). About half of the ovarian cortex
was removed via laparotomy in the therapeutically sur-
gery for the nephroblastom from both ovaries. This pa-
tient and her parents were interested in cryopreserving
ovarian tissue for fertility preservation and to contribute
to research efforts in this area. Less than 5% of the fro-
zen tissue was used for this experiment. A histological
examination of the ovarian cortex was performed prior
to cryopreservation in order to secure a sufficient
amount of primordial follicles and exclude involvement
of the tissue by malignancy.
Ovarian tissue freezing and thawing
Details of the cryopreservation and thawing protocols
for ovarian cortex tissue have been previously described.
In brief, ovarian tissue biopsies were cut into pieces
measuring 1 × 2 × 1 mm and equilibrated in a freezing so-
lution containing 1.5 mol/L dimethylsulfoxide (DMSO) in
Leibovitz medium. The pieces of ovarian tissue were then
frozen in standard cryopreservation containers (1.8 mL
Nunc cryovials) using a slow-cooling protocol with a
closed freezing system (Icecube 14S; Sylab) with auto-
seeding. Cryopreserved ovarian tissue fragments were
transported in a liquid nitrogen dewar to the Erlangen
University Hospital (Erlangen, Germany) for thawing
and transplantation experiments. Rapid thawing took
place in a warm water bath (37°C until thawing). Tissue
fragments were exposed in a step-wise manner to de-
creasing sucrose concentrations to release it from the
protective cryopreservation medium [12].
Animals
Female SCID mice (6 weeks old, Harlan-Winkelmann,
Borchen, Germany) were housed in a high efficiency
particulate air-filtered positive pressure room. Cages
(Techniplast, Milano, Italy) were filter-topped and ani-
mals had access to food (Altromin 1314, Altromin,
Lage, Germany) and water ad libitum under 12 h light:
12 h dark conditions. Groups of 5 mice were housed in
1 cage. Mice underwent a 1 week acclimation period
upon arrival at the facility. All procedures and tests
were performed under a laminar flow hood in a positive
pressure room. Approval for the study was obtainedfrom the local ethical committee on animal experimenta-
tion (Erlangen University Hospital, Erlangen, Germany).
Animals were maintained in accordance with Animal Care
and Use Committee regulations.Transplantation procedure
Surgery was performed under anesthesia with isoflurane
(Isoflo® ad us. vet., Abott AG, Baar, Germany). Trans-
plantation was performed irrespective of the estrous
cycle stage. Mice ovaries were removed and 1 frozen/
thawed human ovarian tissue fragment was placed in an
intramuscular pocket of the neck. Grafting experiments
were carried out in multiple rounds to ensure optimal
technical handling and minimize the number of sacri-
ficed animals.Treatment of the xenografted ovarian tissue
In this particular study, SCID mice and their grafted tis-
sue were not exposed to any exogenous hormones. The
finding was part of a larger study comparing prepubertal
ovarian tissue growth in vivo versus in vitro. Exogenous
hormone administration was not part of the experimen-
tal protocol in either case.Graft observations and oocyte retrieval
Study animals were observed daily for behavior, health and
follicle growth was monitored with palpation of the neck.
On the occasion that a lump was witnessed at the graft site,
the animal was put under general anesthesia (isoflurane,
5%) and any apparent antral follicles were aspirated using a
customized sterile needle (20G Supra, Karl Lettenbauer
GmbH, Erlangen, Germany), specially beveled and sharp-
ened for ease of aspiration and to minimize trauma to sur-
rounding tissue at the site of action. The aspirate was
inspected for the presence of oocytes. Products were
placed into warmed and equilibrated culture medium with-
out exogenous gonadotropins (Universal IVF Medium;
Origio, Malov, Denmark), examined for meiotic stage and
then placed into a 37°C incubator (5% CO2 in air) for
in vitro culture. The animal was returned to its cage for
continued observation following the procedure.Results
On Day 122 post-transplantation, 2 large lumps, ap-
proximately 7 mm each in width, were noticed at the
site of the grafted prepubertal tissue (Figure 1). One oo-
cyte surrounded by a tight layer of cumulus and a sheet
of granulosa cells was recovered from an antral follicle
of the grafted tissue (Figure 2). This oocyte (diameter
150 μm) matured to the MII stage following 22 h of
in vitro culture (Figure 3). The zona pellucida (ZP) was
14,6 μm.
Figure 1 Macroscopic view of large lumps seen at the site of the
grafted prepubertal ovarian tissue Day 122 post-transplantation.
Antral follicles estimated to be ~7 mm in diameter. (A) Dorsal view;
(B) Side view.
Figure 2 One maturing oocyte was recovered from the aspirate
of an antral follicle from the xenotransplanted prepubertal
ovarian tissue (32x magnification).
Figure 3 Morphologically mature metaphase II oocyte following
22 h in in vitro culture. Oocyte measured 150 μm in diameter
(32x magnification).
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Ovarian tissue cryopreservation and transplantation is
proving to be a promising avenue for fertility preserva-
tion. Initial studies on the potential of this technique fo-
cused mainly on adult females for whom maintenance of
fertility may be more of an immediate issue after cancer
treatment. Information gleaned from these studies may
be extrapolated to the adolescent female, for whom
many of the current options of preserving fertility are
not possible or appropriate. Optimization of ovarian tis-
sue collection, preservation and later thawing and trans-
plantation are of the utmost importance in either
situation. In the adolescent female in particular, following
full recovery from cancer, the goal of ovarian transplant-
ation is to support the induction of puberty, establish hor-
monal cyclicity and the conditions for the possibility of an
eventual pregnancy.
The prepubertal ovary has been demonstrated to con-
tain a population of follicles in all stages of growth in ex-
ception of preovulatory stages [5,6]. However, there
appear to be intrinsic differences between the adolescent
and sexually mature ovary that prevent the adolescent
ovary from developing fully mature follicles and oocytes
in situ. It is not clear what these differences may be or
what factors may be involved. Anderson et al. report that
intrafollicular dynamics, local environment and matur-
ational processes that change within the ovary as a girl
ages are all likely involved to varying degrees [13].
Luyckx et al. [8] were the first to demonstrate follicles
contained in prepubertal ovarian tissue can be expected
to function, once transplanted, in a manner comparable
to ovarian tissue from an adult or sexually mature fe-
male. In an effort to improve transplant outcome, the
addition of exogenous hormone stimulation has been
implemented [8,14]. Luyckx et al. [8] demonstrated
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preantral follicles from prepubescent patients after xeno-
transplantation in SCID mice and exogenous hormone
stimulation. The result of finding a Met II oocyte in this
study affirms the results published by Luyckx et al. [8].
The few studies that have reported results from the
autotransplantation of frozen-thawed prepubertal ovarian
tissue demonstrate the possibility of this tissue to induce
puberty and provide some hope for other prepubertal pa-
tients [9,10]. Establishment of follicular development and
hormonal activity in frozen-thawed transplanted pre-
pubertal ovarian tissue has also been demonstrated in ani-
mal models (mouse: [15-17]; nonhuman primate: [18];
sheep: [19]). These results demonstrate the potential of
prepubertal ovarian tissue and further success can be ex-
pected as our understanding of underlying processes and
technique development evolve.
In the current study spontaneous antral follicle forma-
tion and oocyte maturation in a prepubertal ovarian tis-
sue xenotransplant occurred which is in accordance to
the finding that within grafts of adult women spontan-
eous follicle development can take place [20]. To our
knowledge, this is the first report of antral follicular for-
mation and oocyte maturation without exogenous hor-
mone administration in a frozen-thawed ovarian tissue
transplant obtained from a prepubertal patient. Follicle
growth was estimated to be to approximately 7 mm in
width and the obtained oocyte measured 150 μm. The
zona pellucida (ZP) was thin (14,6 μm), but did not sig-
nificantly vary from ZP witnessed in mature oocytes ob-
tained from stimulated in vitro fertilization (IVF) cycles
([21]). This result complements reports on the potential
of frozen-thawed prepubertal tissue to successfully es-
tablish follicular activity [9,10] and indicates for the first
time that prepubertal tissue can produce mature oocytes
after xenotransplantation, even without gonadotropin
stimulation. This may be advantageous for graft survival
since it has been shown that prolonged gonadotropin
stimulation may cause a loss of primordial follicles in xe-
nografts [22-24] or in vitro [25].
There will be cases when transplantation will not be
indicated due to presence of malignant cells within the
transplant [26-28]. Xenotransplantation could be an op-
tion to obtain oocytes which can be used for achieving
pregnancies of these patients. In vitro maturation (IVM)
of oocytes provides an alternative and complementary
technique. This can be accomplished in several ways to
include: supplementary oocyte aspiration from ovarian
tissue prior to ovarian tissue cryopreservation [29,30],
these oocytes may be immediately cultured to maturity
or cryopreserved; in vitro culture of the ovarian tissue
post-thaw to produce antral follicle development and
harvest mature oocytes from the excised tissue either for
immediate use in IVF or for cryopreservation. Anotherpromising option is an artificial ovary with isolated folli-
cles as very recently described [31]. These avoid the po-
tential risk of reintroducing malignant cells and increase
opportunities for the patient’s future reproductive health
and options.
Conclusions
Our finding suggests that it may be possible to accomplish
oocyte maturation during in vitro culture of prepubertal
ovarian tissue, whether within isolated encapsulated folli-
cles or within the ovarian tissue slice itself [7,8]. The SCID
mouse essentially acts as a kind of optimal incubator and
ovarian growth within this system may be mimicked
in vitro once ideal conditions have been established. Fu-
ture studies will continue to focus on optimizing condi-
tions for in vitro growth of ovarian tissue in parallel with
the goals of resumption of hormonal cyclicity, follicle
growth and activity, and oocyte maturation (cytoplasmic
and morphological) in transplanted tissue.
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